Records containing: Hematologic Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-18A Single Center, Pilot Clinical Investigation of Surgical Bleeding in Burn Patients, and Chronically Transfused Patients With Haematologic Malignancies, Who Are Transfused With Hypoxic Red Blood Cells Manufactured With Hemanext ONE System
-
CLINICAL_TRIALS study record update · 2025-05-13A Prospective Study to Validate the Prognostic Power of the Optimized HLH Inflammatory (OHI) Index
-
CLINICAL_TRIALS study record update · 2025-04-10The Use of Genomic Testing and the Resulting Medical Decisions According to Target Identification
-
CLINICAL_TRIALS study record update · 2024-12-27Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
-
CLINICAL_TRIALS study record update · 2024-12-12A Phase I Multi-dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) with or Without Recombinant Human Interleukin-2 (rhIL-2) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) or Relapsed/refractory (R/R) AML
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-04Evaluation of ClearLLab LS Screening Panel for the Diagnosis of Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-21A Study for Safety, Efficacy and Cellular Pharmacokinetics of CD7 CAR-T Cell for Patients With Relapsed or Refractory CD7 Positive T-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
-
CLINICAL_TRIALS study record update · 2024-11-21Clinical Study on Efficacy, Safety and Pharmacokinetics of CAR T Cell Injection in Patients With Recurrent or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-21Efficacy, Safety and Cytopharmacokinetics of RD13-02 Cell Injection in the Treatment of Patients With Recurrent or Refractory CD7-positive Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-19An Open Label, Dose-Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of TAK-981 in Adult Patients With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-10-16Prognostic and Predictive Values of CD155 in Patients With Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2024-10-02A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-free Graft-versus-host Disease Prophylaxis Regimen With Post-transplantation Cyclophosphamide and Abatacept to Standard of Care
-
CLINICAL_TRIALS study record update · 2024-09-03Evaluating Immunological Parameters, Neurocognitive Changes, Activity Levels, and Driving Fitness in Hematological Malignancy Patients Undergoing Chimeric Antigen Receptor (CAR)-T Cell Therapy
-
CLINICAL_TRIALS study record update · 2024-06-04Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia Due to Enterobacteriaceae and Pseudomonas Aeruginosa in Hemato-oncological Patients With Severe Neutropenia and Fever: Non-inferiority Study
-
CLINICAL_TRIALS study record update · 2024-04-01La Piattaforma ACC di Ricerca Preclinica Per l'Oncologia di Precisione
-
CLINICAL_TRIALS study record update · 2023-12-21A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms
-
CLINICAL_TRIALS study record update · 2023-12-21Bleeding in Thrombocytopenia Explained
-
CLINICAL_TRIALS study record update · 2023-06-28Nonmyeloablative Hematopoietic Stem Cell Transplantation (SCT) for High-Risk Hematologic Malignancies With Related, HLA-Haploidentical Donors: A Phase II Trial of Immunosuppression With Cyclophosphamide Administered Before and After SCT
-
CLINICAL_TRIALS study record update · 2023-06-15A Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Subjects With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2023-03-24A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (Relatlimab, BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Relapsed or Refractory B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2023-01-31ClinicalTrials.gov study NCT02623309
-
CLINICAL_TRIALS study record update · 2023-01-05A Multicenter, Phase Ib/II Trial of the Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells in Treatment-induced Myelosuppression in Patients With Hematologic Malignancies (USMYE Trial)
-
CLINICAL_TRIALS study record update · 2022-11-01Efficacy of Mindfulness-based Virtual Reality Intervention on the Symptoms Associated With Hematologic Neoplasms Patients During Chemotherapy
-
CLINICAL_TRIALS study record update · 2022-07-12A Phase I Study of Donor BPX-501 T Cell Infusion for Adults With Recurrent or Minimal Residual Disease Hematologic Malignancies Post-Allogeneic Transplant
-
CLINICAL_TRIALS study record update · 2022-06-08Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA, An Observational Multicenter Study